9120
substituents can be introduced at the primary or secondary rim of the cyclodextrin torus.
Amphiphilic cyclodextrins which have been described so far, include per-derivatives with
3
4
5
alkyl-amino, alkyl-thio, and alkyl-sulfoxo substituents at the primary positions of each
glucose unit of the cyclodextrin. The second type of amphiphilic cyclodextrin possesses the
6
7
hydrophobic functionality attached to the secondary hydroxyl position by an ester or ether
linkage. Long alkyl chains (five–seven carbon atoms) attached via an ether linkage were chosen
to introduce lipophilic character to the secondary face of the cyclodextrin molecule. In our
synthetic approach (Scheme 1), we have regioselectively 6-O-protected the starting a- and
8
b-cyclodextrins using tert-butyldimethylsilyl chloride in pyridine. Treatment of 1 with a 10-fold
excess of alkyl (n-pentyl, n-hexyl, n-heptyl) iodide in DMF in the presence of a 12-fold excess
9
of sodium hydride for
3
days, gave per(6-O-tert-butyldimethylsilyl-2,3-di-O-alkyl)-
cyclomaltooligosaccharides (3a–c) and (4a–c). Derivatives 3a–c and 4a–c were desilylated using
10
a standard procedure (tetrabutylammonium fluoride in boiling tetrahydrofuran) to give
amphiphilic per(2,3-di-O-alkyl)-a, b-cyclodextrins (5a–c) and (6a–c). All the free hydroxy groups
at position C-6 were exchanged to iodo functions by treatment with a toluene solution of
11
triphenylphosphine/I and stoichiometric amounts of imidazole, to give per(6-deoxy-6-iodo-
2
2
,3-di-O-alkyl) derivatives (7a–c) and (8a–c). The S-alkylation reactions between an excess of
benzyl mercaptan and per(6-deoxy-6-iodo) cyclodextrin derivatives 7a–c or 8a–c, were carried
using 3 M sodium methoxide at 60°C in DMF for 24 h to give hexakis(6-thiobenzyl-6-deoxy-2,3-
†
di-O-alkyl)cyclomaltohexaoses (9a–c) in 94, 95, and 85% yield, respectively and heptakis(6-
‡
deoxy-6-S-benzyl-2,3-di-O-alkyl)cyclomaltoheptaoses (10a–c). S-Benzyl functionalities were
introduced at the primary rim of the amphiphilic cyclodextrins in order to recover the anchoring
SH groups by the reductive cleavage of benzyl groups using sodium in liquid ammonia to give
†
22
13
Hexakis(6-deoxy-6-S-Bzl-2,3-di-O-alkyl) a-CD selected data: 9a oil, [h]D +139.0° (c 1, CHCl3); C NMR
CDCl ) l 97.80 (C-1), 81.13 (C-4), 80.08, 71.74 (C-2,3,5), 33.59 (C-6), 37.69 (CH ꢀPh), 138.93, 129.07, 128.24, 126.65
(
(
3
2
Aromatic), 73.92, 71.58 (2×C H ), 30.21, 29.97 (2×C H ), 28.26, 28.19 (2×C H ), 22.81, 22.65 (2×C H ), 14.07, 14.04
2×C H ); LSIMS(+) NBA m/z 2450.2 [M+H] , calc. for C138H216O S 2450.4 [M+H] . Compound 9b oil, [h]
3 24 6 D
107.4° (c 1, CHCl3); C NMR (CDCl ) l 97.96 (C-1), 81.28 (C-4), 80.16, 80.05, 71.79 (C-2,3,5), 33.62 (C-6), 37.72
h
2 i 2 k 2 l 2
+
+
22
(
+
d
13
3
(
(
CH ꢀPh), 138.97, 129.12, 128.29, 126.69 (Aromatic), 74.02, 71.70 (2×C H ), 32.10, 31.90 (2×C H ), 30.56, 30.28
2
h
2
i
2
2×C H ), 25.85, 25.74 (2×C H ), 22.77, 22.70 (2×C H ), 14.08, 14.05 (2×C H ); LSIMS (+) NBA m/z 2618.0
k
2
+
l
2
m
2
d
3
+
24 6 D 3
22
13
[
M+H] , calc. for C150H240O S 2620.6 [M+H] . Compound 9c oil, [h] +212.2° (c 1, CHCl3); C NMR (CDCl ) l
9
8.00 (C-1), 81.36 (C-4), 80.18, 80.00, 71.81 (C-2,3,5), 33.60 (C-6), 37.72 (CH ꢀPh), 138.98, 129.12, 128.28, 126.69
2
(
Aromatic), 74.03, 71.70 (2×C H ), 32.08, 31.95 (2×C H ), 30.66, 30.34 (2×C H ), 29.66, 29.40 (2×C H ), 26.21, 26.04
h
2 i 2 k 2 l 2
+
d
(
2×C H ), 22.70, 22.69 (2×C H ), 14.10(d) (2×C H ); LSIMS (+) NBA m/z 2788.8 [M+H] , calc. for C162H264O S6
2 2 3 24
m
x
+
2789.2 [M+H] .
‡
22
13
Heptakis(6-deoxy-6-S-Bzl-2,3-di-O-alkyl) b-CD selected data: 10a oil, [h]D +220.9° (c 1, CHCl3); C NMR
CDCl ) l 97.83 (C-1), 80.91 (C-4), 80.23, 80.02, 71.75 (C-2,3,5), 33.66 (C-6), 37.69 (CH ꢀPh), 138.85, 129.06, 128.30,
(
1
3
2
26.65 (Aromatic), 73.98, 71.54 (2×C H ), 30.18, 29.91 (2×C H ), 28.32, 28.17 (2×C H ), 22.82, 22.62 (2×C H ),
h
2 i 2 k 2 l 2
+
28 7
+
1
4.07 (2×C H ); LSIMS (+) NBA m/z 2859.5 [M+H] , calc. for C161H252O S 2861.2 [M+H] . Compound 10b oil,
d
3
22
13
D 3
[
h] +112.5° (c 1, CHCl3); C NMR (CDCl ) l 97.90 (C-1), 80.99 (C-4), 80.29, 80.05, 71.78 (C-2,3,5), 33.67 (C-6),
3
3
7.71 (CH ꢀPh), 138.88, 129.11, 128.35, 126.71 (Aromatic), 74.10, 71.68 (2×C H ), 32.13, 31.87 (2×C H ), 30.54,
2
h
2
i
2
0.23 (2×C H ), 25.93, 25.72 (2×C H ), 22.77, 22.73 (2×C H ), 14.09, 14.07 (2×C H ); LSIMS (+) NBA m/z 3054.0
k
2
l
2
m
2
d
2
+
+ 22
28 7 D
13
[
M+H] , calc. for C175H280O S 3057.8 [M+H] . Compound 10c oil, [h] +94.6° (c 0.56, CHCl3); C NMR (CDCl3)
l 97.92 (C-1), 81.03 (C-4), 80.32, 80.05, 71.71 (C-2,3,5), 33.67 (C-6), 37.71 (CH ꢀPh), 138.88, 129.11, 128.35, 126.71
2
(
(
Aromatic), 74.13, 71.71 (2×C H ), 32.07, 31.98 (2×C H ), 30.65, 30.30 (2×C H ), 29.69, 29.39 (2×C H ), 26.27, 26.03
h
2 i 2 k 2 l 2
+
2×C H ), 22.70 (2×C H ), 14.10 (2×C H ); LSIMS(+) NBA m/z 3254.9 [M+H] , calc. for C189H308O S 3253.9
m
2
+
x
2
d
2
28 7
[
M+H] .